These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37164761)

  • 1. How tobacco companies use the revolving door between government and industry to influence policymaking: an Australian case study.
    Watts C; Jones M; Lindorff K; Freeman B
    Public Health Res Pract; 2023 Dec; 33(4):. PubMed ID: 37164761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.
    Lacy-Nichols J; Christie S; Cullerton K
    Health Promot Int; 2023 Oct; 38(5):. PubMed ID: 37864804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian lobbyist registers are not serving the purposes they were designed for.
    Robertson N; Kypri K; Stafford J; Daube M; Avery M; Miller P
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S218-S222. PubMed ID: 28695571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The revolving door between government and the alcohol, food and gambling industries in Australia.
    Robertson NM; Sacks G; Miller PG
    Public Health Res Pract; 2019 Sep; 29(3):. PubMed ID: 31569204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public opinion of alcohol industry corporate political activities.
    Miller P; Martino F; Robertson N; Stafford J; Daube M
    Aust N Z J Public Health; 2021 Jun; 45(3):283-289. PubMed ID: 34028934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021.
    Rotering T; Apollonio DE
    Int J Drug Policy; 2022 Apr; 102():103585. PubMed ID: 35085854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the Lobbying Footprint of Harmful Industries: 23 Years of Data From OpenSecrets.
    Chung H; Cullerton K; Lacy-Nichols J
    Milbank Q; 2024 Mar; 102(1):212-232. PubMed ID: 38219274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State tobacco lobbyists and organizations in the United States: crossed lines.
    Goldstein AO; Bearman NS
    Am J Public Health; 1996 Aug; 86(8):1137-42. PubMed ID: 8712274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'If someone donates $1000, they support you. If they donate $100 000, they have bought you'. Mixed methods study of tobacco, alcohol and gambling industry donations to Australian political parties.
    Kypri K; McCambridge J; Robertson N; Martino F; Daube M; Adams P; Miller P
    Drug Alcohol Rev; 2019 Mar; 38(3):226-233. PubMed ID: 30474155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco lobby political influence on US state legislatures in the 1990s.
    Givel MS; Glantz SA
    Tob Control; 2001 Jun; 10(2):124-34. PubMed ID: 11387532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the influence of the tobacco industry on EU governance: automated content analysis of the EU Tobacco Products Directive.
    Costa H; Gilmore AB; Peeters S; McKee M; Stuckler D
    Tob Control; 2014 Nov; 23(6):473-8. PubMed ID: 25124165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Alcohol Industry Submissions against Marketing Regulation.
    Martino FP; Miller PG; Coomber K; Hancock L; Kypri K
    PLoS One; 2017; 12(1):e0170366. PubMed ID: 28118411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco industry's 'behind the scenes' tactics in Singapore.
    van der Eijk Y; Tan GPP
    Tob Control; 2023 May; 32(3):280-286. PubMed ID: 34452987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State legislators' perceptions of lobbyists and lobbying on tobacco control issues.
    Cohen JE; Goldstein AO; Flynn BS; Munger MC; Gottlieb NH; Solomon LJ; Dana GS
    Tob Control; 1997; 6(4):332-6. PubMed ID: 9583632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco industry interference with tobacco control policies in Poland: legal aspects and industry practices.
    Balwicki Ł; Stokłosa M; Balwicka-Szczyrba M; Tomczak W
    Tob Control; 2016 Sep; 25(5):521-6. PubMed ID: 26418616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of failed tobacco control legislation.
    Moore S; Wolfe SM; Lindes D; Douglas CE
    JAMA; 1994 Oct; 272(15):1171-5. PubMed ID: 7933346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.
    Knight J; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii13-21. PubMed ID: 15564215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the influence of the alcohol industry in Aotearoa New Zealand.
    Leung JY; Randerson S; McLellan G; Casswell S
    N Z Med J; 2023 Jul; 136(1579):104-112. PubMed ID: 37501249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.